Mandate

Vinge advises HH Ferries

September 21, 2018 EU, Competition and Regulatory

Vinge has advised HH Ferries in an action before the EU General Court in Luxembourg in state aid proceedings which primarily relate to state guarantees.

The General Court approved HH Ferries’ action due to, among other things, the European Commission’s deficient review of the amount and time limits as well as the support measures’ proportionality and necessity and thus set aside the European Commission’s decision. 

Vinge’s team primarily consisted of Martin Johansson at the Brussels office as well as Rikard Azelius and Pär Remnelid at the Skåne office.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025